PAREXEL INVITES PUBLIC TO LISTEN TO LIVE WEBCAST OF ITS INVESTOR DAY APRIL 9, 2003
BOSTON, MA, March 25, 2003 — PAREXEL International Corporation (Nasdaq: PRXL), one of the largest contract pharmaceutical outsourcing organizations in the world, announced today that it will broadcast its Investor Day live over the Internet on Wednesday, April 9th from 8:30 a.m. to 12:30 p.m. ET.
PAREXEL will be discussing its growth strategy and vision for its markets, as well as its broad range of knowledge-based services. The day will include presentations and comments by the executive management team, including the Presidents of each of the Company’s business units.
Those who wish to listen to the Investor Day presentations and view the accompanying slides should log on to the Company’s website at www.parexel.com, click on “Investor Relations”, and then “Webcasts” fifteen minutes prior to the event to register, download and install any necessary software. After the conference, the event’s presentations will be archived and available on the Company’s website until April 23, 2003.
PAREXEL is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services. Its information technology subsidiary, Perceptive Informatics, Inc., provides a variety of technology products and services, including web-based portal solutions and voice and data systems, and the use and interpretation of medical images as clinical trial endpoints, which are designed to accelerate and enhance the clinical development and launch processes. The Company’s integrated services, therapeutic area depth and sophisticated information technology, along with its experience in global drug development and product launch services, represent key competitive strengths. Headquartered near Boston, MA, PAREXEL operates in 58 locations throughout 35 countries around the world, and has approximately 4,970 employees.